These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 32256201)
21. Comparison of clinical and neuropathological diagnoses of neurodegenerative diseases in two centres from the Brains for Dementia Research (BDR) cohort. Selvackadunco S; Langford K; Shah Z; Hurley S; Bodi I; King A; Aarsland D; Troakes C; Al-Sarraj S J Neural Transm (Vienna); 2019 Mar; 126(3):327-337. PubMed ID: 30730007 [TBL] [Abstract][Full Text] [Related]
22. Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort. Bocchetta M; Todd EG; Bouzigues A; Cash DM; Nicholas JM; Convery RS; Russell LL; Thomas DL; Malone IB; Iglesias JE; van Swieten JC; Jiskoot LC; Seelaar H; Borroni B; Galimberti D; Sanchez-Valle R; Laforce R; Moreno F; Synofzik M; Graff C; Masellis M; Tartaglia MC; Rowe JB; Vandenberghe R; Finger E; Tagliavini F; de Mendonça A; Santana I; Butler CR; Ducharme S; Gerhard A; Danek A; Levin J; Otto M; Sorbi S; Le Ber I; Pasquier F; Rohrer JD; Brain Commun; 2023; 5(2):fcad061. PubMed ID: 36970046 [TBL] [Abstract][Full Text] [Related]
23. Molecular imaging of dementia. Mori T; Maeda J; Shimada H; Higuchi M; Shinotoh H; Ueno S; Suhara T Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644 [TBL] [Abstract][Full Text] [Related]
24. Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid. Rosenberg A; Solomon A; Jelic V; Hagman G; Bogdanovic N; Kivipelto M Alzheimers Res Ther; 2019 Dec; 11(1):99. PubMed ID: 31805990 [TBL] [Abstract][Full Text] [Related]
25. Spatial Navigation and Its Association With Biomarkers and Future Dementia in Memory Clinic Patients Without Dementia. Tangen GG; Nilsson MH; Stomrud E; Palmqvist S; Hansson O Neurology; 2022 Nov; 99(19):e2081-e2091. PubMed ID: 36028328 [TBL] [Abstract][Full Text] [Related]
26. Tackling Dementia Together via The Australian Dementia Network (ADNeT): A Summary of Initiatives, Progress and Plans. Naismith SL; Michaelian JC; Santos C; Mehrani I; Robertson J; Wallis K; Lin X; Ward SA; Martins R; Masters CL; Breakspear M; Ahern S; Fripp J; Schofield PR; Sachdev PS; Rowe CC J Alzheimers Dis; 2023; 96(3):913-925. PubMed ID: 37927266 [TBL] [Abstract][Full Text] [Related]
27. Impact of a Clinical Decision Support Tool on Dementia Diagnostics in Memory Clinics: The PredictND Validation Study. Bruun M; Frederiksen KS; Rhodius-Meester HFM; Baroni M; Gjerum L; Koikkalainen J; Urhemaa T; Tolonen A; van Gils M; Tong T; Guerrero R; Rueckert D; Dyremose N; Andersen BB; Simonsen AH; Lemstra A; Hallikainen M; Kurl S; Herukka SK; Remes AM; Waldemar G; Soininen H; Mecocci P; van der Flier WM; Lötjönen J; Hasselbalch SG Curr Alzheimer Res; 2019; 16(2):91-101. PubMed ID: 30605060 [TBL] [Abstract][Full Text] [Related]
28. Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study. Mutsaerts HJMM; Mirza SS; Petr J; Thomas DL; Cash DM; Bocchetta M; de Vita E; Metcalfe AWS; Shirzadi Z; Robertson AD; Tartaglia MC; Mitchell SB; Black SE; Freedman M; Tang-Wai D; Keren R; Rogaeva E; van Swieten J; Laforce R; Tagliavini F; Borroni B; Galimberti D; Rowe JB; Graff C; Frisoni GB; Finger E; Sorbi S; de Mendonça A; Rohrer JD; MacIntosh BJ; Masellis M; Brain; 2019 Apr; 142(4):1108-1120. PubMed ID: 30847466 [TBL] [Abstract][Full Text] [Related]
29. Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study. van der Ende EL; Meeter LH; Poos JM; Panman JL; Jiskoot LC; Dopper EGP; Papma JM; de Jong FJ; Verberk IMW; Teunissen C; Rizopoulos D; Heller C; Convery RS; Moore KM; Bocchetta M; Neason M; Cash DM; Borroni B; Galimberti D; Sanchez-Valle R; Laforce R; Moreno F; Synofzik M; Graff C; Masellis M; Carmela Tartaglia M; Rowe JB; Vandenberghe R; Finger E; Tagliavini F; de Mendonça A; Santana I; Butler C; Ducharme S; Gerhard A; Danek A; Levin J; Otto M; Frisoni GB; Cappa S; Pijnenburg YAL; Rohrer JD; van Swieten JC; Lancet Neurol; 2019 Dec; 18(12):1103-1111. PubMed ID: 31701893 [TBL] [Abstract][Full Text] [Related]
30. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R; Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606 [TBL] [Abstract][Full Text] [Related]
31. Situated Prevention: Framing the "New Dementia". Leibing A J Law Med Ethics; 2018 Sep; 46(3):704-716. PubMed ID: 30336105 [TBL] [Abstract][Full Text] [Related]
32. Addressing ethical challenges of disclosure in dementia prediction: limitations of current guidelines and suggestions to proceed. Alpinar-Sencan Z; Schicktanz S BMC Med Ethics; 2020 May; 21(1):33. PubMed ID: 32393330 [TBL] [Abstract][Full Text] [Related]
33. Prevalence of abnormal Alzheimer's disease biomarkers in patients with subjective cognitive decline: cross-sectional comparison of three European memory clinic samples. Wolfsgruber S; Molinuevo JL; Wagner M; Teunissen CE; Rami L; Coll-Padrós N; Bouwman FH; Slot RER; Wesselman LMP; Peters O; Luther K; Buerger K; Priller J; Laske C; Teipel S; Spottke A; Heneka MT; Düzel E; Drzezga A; Wiltfang J; Sikkes SAM; van der Flier WM; Jessen F; Alzheimers Res Ther; 2019 Jan; 11(1):8. PubMed ID: 30654834 [TBL] [Abstract][Full Text] [Related]
34. Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort: The ABIDE Project. de Wilde A; van der Flier WM; Pelkmans W; Bouwman F; Verwer J; Groot C; van Buchem MM; Zwan M; Ossenkoppele R; Yaqub M; Kunneman M; Smets EMA; Barkhof F; Lammertsma AA; Stephens A; van Lier E; Biessels GJ; van Berckel BN; Scheltens P JAMA Neurol; 2018 Sep; 75(9):1062-1070. PubMed ID: 29889941 [TBL] [Abstract][Full Text] [Related]
35. Epidemiology of Dementia: The Burden on Society, the Challenges for Research. Wolters FJ; Ikram MA Methods Mol Biol; 2018; 1750():3-14. PubMed ID: 29512062 [TBL] [Abstract][Full Text] [Related]
36. Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia. Jack CR; Wiste HJ; Therneau TM; Weigand SD; Knopman DS; Mielke MM; Lowe VJ; Vemuri P; Machulda MM; Schwarz CG; Gunter JL; Senjem ML; Graff-Radford J; Jones DT; Roberts RO; Rocca WA; Petersen RC JAMA; 2019 Jun; 321(23):2316-2325. PubMed ID: 31211344 [TBL] [Abstract][Full Text] [Related]
37. Upgraded Methodology for the Development of Early Diagnosis of Parkinson's Disease Based on Searching Blood Markers in Patients and Experimental Models. Kim A; Nigmatullina R; Zalyalova Z; Soshnikova N; Krasnov A; Vorobyeva N; Georgieva S; Kudrin V; Narkevich V; Ugrumov M Mol Neurobiol; 2019 May; 56(5):3437-3450. PubMed ID: 30128652 [TBL] [Abstract][Full Text] [Related]
38. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia]. Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ; Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080 [TBL] [Abstract][Full Text] [Related]
39. The role of Memory Clinics in the assessment and management of dementia, now and into the future. Mehrani I; Sachdev PS Curr Opin Psychiatry; 2022 Mar; 35(2):118-122. PubMed ID: 35026801 [TBL] [Abstract][Full Text] [Related]